In another study involving patients with triple-negative breast cancer (TNBC), which lacks expression of ER, PgR, and HER2, a higher incidence of lung cancer and lower overall survival rates were observed compared to patients with ER and PgR positivity [105]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.